For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of Tafamidis and Tafamidis meglumine represents a significant breakthrough . These groundbreaking therapies protect the transthyretin protein, halting its destructive build-up and reducing the severity of the condition . Patients are now … Read More